FDA publishes Q8/Q9/Q10 Implementation Document
On November 1, 2011 the USA FDA published the Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4). This guidance was developed within the Quality Implementation Working Group of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). According to the ICH process it has been subject to consultation by the regulatory parties. The answers to questions in this document have been endorsed by the ICH Steering Committee at Step 4 of the ICH process in April 2009, June 2009, October 2009, and November 2010. In Step 4 of the process, the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan, and the United States. The Q&A document was already published in Europe and in Japan.
The guidance reflects the current working procedure of the ICH Quality Implementation Working Group (Q-IWG) for implementing the Q8, Q9, and Q10 guidances. The document contains the following topics:
- Quality by Design
- Design Space
- Real Time Release Testing
- Control Strategy - Pharmaceutical Quality System
- Impact of new ICH Quality Guidance on GMP Inspection Practices
- Knowledge Management
- Sofware Solutions
Here you will find the FDA Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4)
Source: Press Release FDA
Related GMP News
17.09.2025When Training Falls Short: FDA Findings on GMP Training Deficiencies in 2025
17.09.2025Dealing with Systems without Audit Trail Functionality
17.09.2025Why is RCA (Root Cause Analysis) so important?
10.09.2025The Use of Hoses in Pharmaceutical Production
10.09.2025Revision of EU-GMP Chapter 1 planned with Consultation Phase
10.09.2025Audit Trail Review by the QP / Dealing with a Lack of Justification